1. Home
  2. TBI vs HUMA Comparison

TBI vs HUMA Comparison

Compare TBI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$8.28

Market Cap

211.3M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.66

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBI
HUMA
Founded
1985
2004
Country
United States
United States
Employees
N/A
184
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.3M
191.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TBI
HUMA
Price
$8.28
$0.66
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$6.00
$6.19
AVG Volume (30 Days)
336.6K
18.0M
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.25
$444.16
Revenue Next Year
$3.90
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.18
$0.55
52 Week High
$8.90
$2.84

Technical Indicators

Market Signals
Indicator
TBI
HUMA
Relative Strength Index (RSI) 65.03 36.22
Support Level $4.57 $0.65
Resistance Level N/A $1.26
Average True Range (ATR) 0.58 0.07
MACD 0.04 0.00
Stochastic Oscillator 73.68 10.91

Price Performance

Historical Comparison
TBI
HUMA

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: